Murine interferon-alpha1 gene-transduced ESb tumor cells are rejected by host-mediated mechanisms despite resistance of the parental tumor to interferon-alpha/beta therapy.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Cancer Gene Therapy

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10359210
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In situ activation of syngeneic tumour-specific cytotoxic T lymphocytes: Intra-pinna immunization followed by restimulation in the peritoneal cavity

  2005cited by this paper
• Induction of Bystander T Cell Proliferation by Viruses and Type I Interferon in Vivo

  1996cited by this paper
• The potential applications of gene transfer in the treatment of patients with cancer: a concise review.

  1996cited by this paper
• Local and systemic response of mice to interferon-alpha 1-transfected Friend leukemia cells.

  1995cited by this paper
• Host CD4+ T lymphocytes are required for the synergistic action of interferon-alpha/beta and adoptively transferred immune cells in the inhibition of visceral ESb metastases.

  1995cited by this paper
• Differential induction of the two early genes c‐jun and c‐fos in weakly and strongly metastatic murine lymphoma cell lines

  1994cited by this paper
• IFN-alpha 1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+ T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma-producing TS/A cells.

  1994cited by this paper
• Successful immunotherapy of the highly metastatic murine ESb lymphoma with sensitized CD8+ T cells and IFN-alpha/beta.

  1994cited by this paper
• Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells.

  1993cited by this paper
• Expression of tumor necrosis factor by different tumor cell lines results either in tumor suppression or augmented metastasis

  1993cited by this paper
• Expression of L1 cell adhesion molecule is associated with lymphoma growth and metastasis

  1993cited by this paper
• Isolation and characterization of a metastatic Eb-like tumor variant highly responsive to interleukin (IL)-2 and to combination cytokine therapy with IL-2/IL-1 beta and IL-1 beta/interferon-alpha/beta.

  1993cited by this paper
• Human immunodeficiency virus (HIV)-infected tumor xenografts as an in vivo model for antiviral therapy: role of alpha/beta interferon in restriction of tumor growth in nude mice injected with HIV-infected U937 tumor cells

  1991cited by this paper
• Modification of tumor cells by a low dose of Newcastle disease virus. III. Potentiation of tumor-specific cytolytic T cell activity via induction of interferon-alpha/beta.

  1990cited by this paper
• Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. III. Postoperative activation of tumor-specific CTLP from mice with metastases requires stimulation with the specific antigen plus additional signals.

  1989cited by this paper
• Antitumor effects of interferon.

  1989cited by this paper
• Improved retroviral vectors for gene transfer and expression.

  1989cited by this paper
• Construction and use of a safe and efficient amphotropic packaging cell line.

  1988cited by this paper
• Interferon treatment markedly inhibits the development of tumor metastases in the liver and spleen and increases survival time of mice after intravenous inoculation of friend erythroleukemia cells

  1988cited by this paper
• A safe packaging line for gene transfer: separating viral genes on two different plasmids

  1988cited by this paper
• Studies on the expression of spontaneous and induced interferons in mouse peritoneal macrophages by means of monoclonal antibodies to mouse interferons.

  1987cited by this paper
• Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. I. Parameters for optimal therapeutic effects

  1986cited by this paper
• Structure and expression of cloned murine IFN-alpha genes.

  1983cited by this paper
• Antitumor effects of interferon in mice injected with interferon‐sensitive and interferon‐resistant friend leukemia cells. III. Inhibition of growth and necrosis of tumors implanted subcutaneously

  1983cited by this paper
• Isolation of interferon-resistant variants of Friend erythroleukemia cells: effects of interferon and ouabain.

  1982cited by this paper
• Antitumor effects of interferon in mice injected with interferon‐sensitive and interferon‐resistant friend leukemia cells. I.

  1982cited by this paper
• Tumor metastases and cell‐mediated immunity in a model system in DBA/2 mice.: Iv. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes

  1979cited by this paper
• Tumor metastases and cell‐mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastasis formation in vivo

  1979cited by this paper

• Aspirin enhances IFN-α-induced growth inhibition and apoptosis of hepatocellular carcinoma via JAK1/STAT1 pathway

  2013cites this paper
• The anticancer face of interferon alpha (IFN-alpha): from biology to clinical results, with a focus on melanoma.

  2010cites this paper
• IFN-alpha and novel strategies of combination therapy for cancer.

  2007cites this paper
• Interferon-alpha and cancer: mechanisms of action and new perspectives of clinical use.

  2007cites this paper
• IFN‐α and Novel Strategies of Combination Therapy for Cancer

  2007cites this paper
• Differential Growth of IFN-β-Engineered Tumor Cells in Nude and IFN Receptor-Null Mice

  2006cites this paper
• Interferon-alpha in tumor immunity and immunotherapy.

  2002cites this paper
• Antitumor activity of recombinant adenoviral vectors expressing murine IFN-α in mice injected with metastatic IFN-resistant tumor cells

  2001cites this paper
• Type I consensus interferon (CIFN) gene transfer into human melanoma cells up-regulates p53 and enhances cisplatin-induced apoptosis: implications for new therapeutic strategies with IFN-alpha

  2000cites this paper
• Gene therapy of cancer with interferon: lessons from tumor models and perspectives for clinical applications.

  2000cites this paper